Sudhir Sundar Rajan, MD
Internal Medicine · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 25 years
- Graduated 2001
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rajan’s office at (408) 851-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A85191 · Current
Licensed to practise in California · since 2003 · expires 2029-01-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Critical Care Medicine
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Pulmonary Disease
Original Medicare doctor bills
$1,783
Medicare paid this office $1,783 for 15 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
15 Original Medicare patients in 2024. Average age 67 · Health risk score 2.86. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 73%.
The office billed $6,552, Medicare allowed $2,330 and paid $1,783; for 25 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 15 | 25 | 67 | 2.86 | $6,552 | $1,783 |
| 2021 | 13 | 21 | 77 | 3.19 | $3,596 | $1,438 |
| 2020 | 14 | 32 | 75 | 3.84 | $5,057 | $2,161 |
| 2019 | 11 | 12 | 75 | 2.04 | $2,302 | $628 |
| 2018 | 14 | 23 | 68 | 2.65 | $4,557 | $1,462 |
| 2015 | 12 | 19 | 71 | 2.83 | $4,444 | $1,260 |
| 2013 | 11 | 25 | 72 | 3.27 | $6,147 | $1,732 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2020: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,931 | $67 |
2018: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $942 | $59 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 11 Part D prescriptions in 2017. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2017 | 11 | None | 0% (0) | None | $115 |
| 2016 | 17 | None | 0% (0) | None | $222 |
| 2015 | 31 | None | 0% (0) | None | $456 |
| 2014 | 58 | None | None | 31% | $1,121 |
| 2013 | 424 | 24 | 4% (17) | 22% | $13,935 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2016: 1 drug
| Donepezil | 12 | $149 | $12 |
2015: 1 drug
| Donepezil | 12 | $121 | $10 |
2014: 1 drug
| Donepezil | 12 | $160 | $13 |
2013: 11 drugs
| Crestor | 16 | $1,161 | $73 |
| Donepezil | 28 | $816 | $29 |
| Losartan | 21 | $585 | $28 |
| Famotidine | 44 | $396 | $9 |
| Amlodipine Besylate | 22 | $256 | $12 |
| Carvedilol | 20 | $219 | $11 |
| Risperidone | 18 | $213 | $12 |
| Simvastatin | 11 | $116 | $11 |
| Baclofen | 12 | $90 | $8 |
| Hydrochlorothiazide | 12 | $89 | $7 |
| Hydrocodone-Acetaminophen | 16 | $67 | $4 |
Money from drug and device companies
$225 in 2019
A payment is not proof that care is biased.
| Boehringer Ingelheim Pharmaceuticals | Ofev | $225 | 2 payments
|
See all 2 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2019-10-19 | Ofev | $99 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2019-06-27 | None | $125 |
Professional record
- NPI
- 1396961249
- Licence
- CA A85191California A85191: Current · expires 2029-01-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 50 Blossom, Irvine, CA, 92620
- NPI first listed
- 2007-04-18
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.